Tumor Budding and Poorly Differentiated Clusters are Unfavorable Prognostic Factors in Pancreatic Ductal Adenocarcinoma, as Validated by the ITBCC Scoring System

被引：0
|
作者：
Anderson, Sarah [1 ]
Patel, Krutika [2 ]
Mneimneh, Wadad [3 ]
Hameed, Nadia [4 ]
Tan, Marcus [2 ]
Jalikis, Florencia [2 ]
机构：
[1] Univ Alabama Birmingham, Birmingham, AL USA
[2] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[3] Case Western Reserve Univ, Cleveland, OH 44106 USA
[4] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
LABORATORY INVESTIGATION | 2022年 / 102卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1113
引用
收藏
页码：1208 / 1208
页数：1
相关论文
共 45 条
  • [31] Features of Immune Cells and the Tumor-Associated Stroma Tango as Prognostic Factors in Patients With Pancreatic Ductal Adenocarcinoma
    Sonohara, Fuminori
    Goel, Ajay
    GASTROENTEROLOGY, 2018, 155 (05) : 1312 - 1314
  • [32] Prognostic significance of growth factors and the urokinase-type plasminogen activator system in pancreatic ductal adenocarcinoma
    Xue, Aiqun
    Scarlett, Christopher J.
    Jackson, Christopher J.
    Allen, Barry J.
    Smith, Ross C.
    PANCREAS, 2008, 36 (02) : 160 - 167
  • [33] Tumor Budding Score Is a Strong and Independent Prognostic Factor in Patients With Pancreatic Ductal Adenocarcinoma: An Evaluation of Whole Slide Pathology Images of Large Sections
    Jiang, Hui
    Yang, Yelin
    Qian, Yuping
    Shao, Chengwei
    Lu, Jianping
    Bian, Yun
    Zheng, Jianming
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [34] Prognostic Role of High-Grade Tumor Budding in Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis with a Focus on Epithelial to Mesenchymal Transition
    Lawlor, Rita T.
    Veronese, Nicola
    Nottegar, Alessia
    Malleo, Giuseppe
    Smith, Lee
    Demurtas, Jacopo
    Cheng, Liang
    Wood, Laura D.
    Silvestris, Nicola
    Salvia, Roberto
    Scarpa, Aldo
    Luchini, Claudio
    CANCERS, 2019, 11 (01)
  • [35] A Novel Combined Tumor Budding-Poorly Differentiated Clusters Grading System Predicts Recurrence and Survival in Stage I-III Colorectal Cancer
    Shivji, Sameer
    Cyr, David P.
    Pun, Cherry
    Duan, Kai
    Sari, Aysegul
    Tomin, Rossi
    Ng, Deanna
    Brar, Amanpreet
    Zerhouni, Siham
    Kennedy, Erin
    Brar, Mantaj
    Swallow, Carol J.
    Conner, James
    Kirsch, Richard
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2022, 46 (10) : 1340 - 1351
  • [36] The prognostic significance of growth pattern, tumor budding, poorly differentiated clusters, desmoplastic reaction pattern and tumor-stroma ratio in colorectal cancer and an evaluation of their relationship with KRAS, NRAS, BRAF mutations
    Kocabey, Duygu Unal
    Cakir, I. Ebru
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2024, 73
  • [37] Histologic Tumor Grade and Preoperative Bilary Drainage are the Unique Independent Prognostic Factors of Survival in Pancreatic Ductal Adenocarcinoma Patients After Pancreaticoduodenectomy
    Macias, Nicolas
    Sayagues, Jose M.
    Esteban, Carmen
    Iglesias, Manuel
    Gonzalez, Luis M.
    Quinones-Sampedro, Jose
    Gutierrez, Maria L.
    Corchete, Luis A.
    Abad, Maria M.
    Bengoechea, Oscar
    Munoz-Bellvis, Luis
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2018, 52 (02) : E11 - E17
  • [38] Tumor Stroma Area and Other Prognostic Factors for Survival and Disease-Free Survival in Pancreatic Ductal Adenocarcinoma Patients Submitted to Operation
    Brito Amaral, Maria Joao O. S.
    Amaral, Mariana
    Freitas, Joao Miguel
    Oliveira, Rui C.
    Serodio, Marco Gil
    Tralhao, Jose G.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2022, 235 (05) : S158 - S158
  • [39] ASO Author Reflections: Prognostic Index after Neoadjuvant Chemotherapy (PINC) in Pancreatic Ductal Adenocarcinoma as Novel Tumor Regression Grading System
    Redegalli, Miriam
    Lena, Marco Schiavo
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (06) : 3503 - 3503
  • [40] ASO Author Reflections: Prognostic Index after Neoadjuvant Chemotherapy (PINC) in Pancreatic Ductal Adenocarcinoma as Novel Tumor Regression Grading System
    Miriam Redegalli
    Marco Schiavo Lena
    Annals of Surgical Oncology, 2022, 29 : 3503 - 3503
12345